Endobronchial valve treatment for emphysema is supported by a rich body of high-quality evidence, and is now a compelling alternative to lung volume reduction surgery (also evidence level A); ...
CENTER VALLEY, Pa., March 29, 2019 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses ...
The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...
LONDON, United Kingdom — An endobronchial valve placed in the lung of a patient with homogeneous emphysema can lead to clinically meaningful improvements in lung function, exercise tolerance, and ...
Symptoms of dyspnea in a patient with chronic obstructive pulmonary disease (COPD), which were caused by pulmonary hyperinflation, were improved by endobronchial valve treatment. Endobronchial valve ...
Pulmonary emphysema Bronchoscopic lung volume reduction with valve replacement shows the most promise for improving lung function, exercise tolerance, and quality of life in patients with advanced ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx Corporation is announcing that over 20,000 patients have been treated worldwide with their Zephyr® ...
CENTER VALLEY, Pa., June 23, 2020 /PRNewswire/ -- Olympus recently announced an expansion of insurance coverage for the Spiration® Valve System, which has been demonstrated to improve quality of life ...
Sept. 8, 2017--People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a ...
WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...
New Data Presented at ATS 2021 International Conference Shows Positive, Sustained Benefits to Patients Treated with this First Minimally Invasive, Non-drug Treatment Option REDWOOD CITY, Calif., May ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that the 2020 update from the Global Initiative for Chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results